April 17, 2019
Bardy Diagnostics, maker of an adhesive ambulatory cardiac patch for remote monitoring, has raised $35.5 million in a Series B funding round led by River Cities Capital Funds. The round also featured participation from newcomers HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures and Rex Health Ventures, as well as returning backers SV Health Investors, Health...
November 15, 2017
Connected wearable patch makers will ship 35.1 million units annually by 2022, with 80 percent of these being used in clinical applications, according to a recent report from market intelligence firm Tractica.
The report also forecasts a total $7.9 billion in revenue for the patch market by the same year, all of which suggests a substantial escalation from the 966,000 units the analysts wrote...
October 12, 2015
Belfast, Northern Ireland-based Intelesens has received FDA 510(k) clearance for its wearable vital signs monitor, called zensor, designed for monitoring patients outside the hospital.
“This is a significant milestone for Intelesens and zensor," Intelesens Commercial Manager Stephen Henderson said in a statement. "...Not only does FDA clearance give the company access to the world’s biggest...
May 18, 2015
Research firm Tractica predicts that worldwide unit shipments of clinical and non-clinical connected wearable patches will grow to 12.3 million per year by 2020. Last year, annual shipments were just 67,000. The market for such connected patches, Tractica predicts, will hit $3.3 billion per year.
Tractica describes the category as including "patches, tattoos, or small devices that are affixed to...